These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30258017)

  • 1. Global and regional brain hypometabolism on FDG-PET in treated HIV-infected individuals.
    Hammoud DA; Sinharay S; Steinbach S; Wakim PG; Geannopoulos K; Traino K; Dey AK; Tramont E; Rapoport SI; Snow J; Mehta NN; Smith BR; Nath A
    Neurology; 2018 Oct; 91(17):e1591-e1601. PubMed ID: 30258017
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Lyra V; Parissis J; Kallergi M; Rizos E; Filippatos G; Kremastinos D; Chatziioannou S
    Eur J Heart Fail; 2020 Nov; 22(11):2138-2146. PubMed ID: 32530569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism.
    Georgiou MF; Gonenc A; Waldrop-Valverde D; Kuker RA; Ezuddin SH; Sfakianakis GN; Kumar M
    J Nucl Med; 2008 Dec; 49(12):1999-2005. PubMed ID: 18997046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
    Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal patterns of regional brain
    Pourhassan Shamchi S; Khosravi M; Taghvaei R; Zirakchian Zadeh M; Paydary K; Emamzadehfard S; Werner TJ; Høilund-Carlsen PF; Alavi A
    Hell J Nucl Med; 2018; 21(3):175-180. PubMed ID: 30411727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk.
    Borja AJ; Hancin EC; Zhang V; Koa B; Bhattaru A; Rojulpote C; Detchou DK; Aly M; Kaghazchi F; Gerke O; Patil S; Gonuguntla K; Werner TJ; Revheim ME; Høilund-Carlsen PF; Alavi A
    Nucl Med Commun; 2021 Apr; 42(4):444-450. PubMed ID: 33323870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.
    Martin C; Castaigne C; Tondeur M; Flamen P; De Wit S
    HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI.
    Seraj SM; Al-Zaghal A; Zadeh MZ; Jahangiri P; Pournazari K; Raynor WY; Werner TJ; Høilund-Carlsen PF; Alavi A; Hunt SJ
    Nucl Med Commun; 2019 May; 40(5):545-551. PubMed ID: 30807535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative Assessment of
    Minamimoto R; Xu G; Jamali M; Holley D; Barkhodari A; Zaharchuk G; Iagaru A
    AJR Am J Roentgenol; 2017 Nov; 209(5):1136-1142. PubMed ID: 28777652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal brain metabolism on FDG PET/MRI during childhood and adolescence.
    Barber TW; Veysey D; Billah B; Francis P
    Nucl Med Commun; 2018 Nov; 39(11):1022-1032. PubMed ID: 30198972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
    Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
    JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological uptake values of 18F-FDG in long bones of the lower extremity on PET/CT imaging.
    van Vliet KE; van Eck-Smit BL; de Jong VM; Goslings JC; Schep NW; Termaat MF
    Nucl Med Commun; 2016 Jun; 37(6):589-92. PubMed ID: 26849073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
    Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
    J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of atherosclerotic inflammation and calcification in subjects with end stage renal disease (ESRD) on hemodialysis to normal controls utilizing
    Bural GG; Torigian DA; Sözmen M; Houseni M; Alavi A
    Hell J Nucl Med; 2018; 21(3):169-174. PubMed ID: 30411726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers.
    Mosci C; Kumar M; Smolarz K; Koglin N; Stephens AW; Schwaiger M; Gambhir SS; Mittra ES
    Radiology; 2016 Jun; 279(3):898-905. PubMed ID: 26785040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
    Kitao T; Shiga T; Hirata K; Sekizawa M; Takei T; Yamashiro K; Tamaki N
    Ann Nucl Med; 2019 Jan; 33(1):22-31. PubMed ID: 30196378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
    Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
    Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.
    Peric S; Brajkovic L; Belanovic B; Ilic V; Salak-Djokic B; Basta I; Rakocevic Stojanovic V
    J Neurol Sci; 2017 Jul; 378():187-192. PubMed ID: 28566162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.